Inducible expression of a mutant form of MEK1 in Swiss 3T3 cells

Journal of Cellular Biochemistry

Volumn 67, Issue 3, 1997, Pages 367-377

  Syu, Li Jyun ^a,b   Guan, Kun Liang ^b   Saltiel, Alan R ^a,b  

^a PFIZER INC   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Dominant negative mutant; MAP kinase; MEK; Proliferation

Indexed keywords

DNA; MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ARTICLE; DNA SYNTHESIS; ENZYME ACTIVATION; ENZYME STRUCTURE; GROWTH REGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION;

3T3 CELLS; ANIMALS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; DNA; ENZYME ACTIVATION; ENZYME INDUCTION; EPIDERMAL GROWTH FACTOR; MAP KINASE KINASE 1; MEMBRANE PROTEINS; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; MUTATION; PHOSPHORYLATION; PLATELET-DERIVED GROWTH FACTOR; PROMOTER REGIONS (GENETICS); PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS C-RAF; RIBOSOMAL PROTEIN S6 KINASES; SON OF SEVENLESS PROTEINS; TETRACYCLINE;

EID: 0030703718     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19971201)67:3<367::AID-JCB8>3.0.CO;2-U     Document Type: Article

References (36)

1. raf-1. EMBO J 7:1610-1619.
2. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR (1995): PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 270:27489-27494.
3. Bardwell L, Thorner J (1996): A conserved motif at the amino termini of MEKs might mediate high-affinity interaction with the cognate MAPKs. Trends Biochem Sci. 21:373-374.
4. Bardwell L, Cook JG, Chang EC, Cairns BR, Thorner J (1996): Signaling in the yeast pheromone response pathway: specific and high-affinity interaction of the mitogen-activated protein(MAP) kinases Kssl and Fus3 with the upstream MAP kinase kinase Ste7. Mol Cell Biol 16:3637-3650.
5. Blenis J (1993): Signal transduction via the MAP kinases: Proceed at your own RSK. Proc Natl Acad Sci USA 90:5889-5892.
6. Boulton TG, Nye SH, Robbins DJ, Ip NY, Radziejewska E, Morgenbesser SD, DePinho RA, Panayotatos N, Cobb MH, Yancopoulos GD (1991): ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell 65:663-675.
7. Burgering BMT, de Vries-Smits AMM, Medema RH, van Weeren P, Tertoolen LGJ, Bos JL (1993): Epidermal growth factor induces phosphorylation of extracellular signal-regulated kinase 2 via multiple pathways. Mol Cell Biol 13:7248-7256.
8. Casillas AM, Amaral K, Chegini-Farahani S, Nel AE (1993): Okadaic acid activates p42 mitogen-activated protein kinase(MAP kinase; ERK-2) in B-lymphocytes but inhibits rather than augments cellular proliferation: contrast with phorbol 12-myristate 13-acetate. Biochem J 290:545-550.
9. Catling AD, Schaeffer H-J, Reuter CWM, Reddy GR, Weber MJ (1995): A proline-rich sequence unique to MEK1 and MEK2 is required for Raf binding and regulates MEK function. Mol Cell Biol 15:5214-5225.
10. Chen D, Waters SB, Holt KH, Pessin JE (1996): SOS phosphorylation and disassociation of the Grb2-SOS complex by the ERK and JNK signaling pathways. J Biol Chem 271:6328-6332.
11. Cowley S, Paterson H, Kemp P, Marshall CJ (1994): Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77:841-852.
12. Dudley DT, Pang L, Decker SJ, Bridges AJ, Saltiel AR (1995): A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci USA 92:7686-7689.
13. Gossen M, Bujard H (1992): Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 89:5547-5551.
14. Haystead CM, Gregory P, Shirazi A, Fadden P, Mosse C, Dent P, Haystead TA (1994): Insulin activates a novel adipocyte mitogen-activated protein kinase kinase kinase that shows rapid phasic kinetics and is distinct from c-Raf. J Biol Chem 269:12804-12808.
15. Howe LR, Leevers SJ, Gómez N, Nakielny S, Cohen P, Marshall CJ (1992): Activation of the MAP kinase pathway by the protein kinase Raf. Cell 71:335-342.
16. Huang W, Erikson RL (1994): Constitutive activation of MEK1 by mutation of serine phosphorylation sites. Proc Natl Acad Sci USA 91:8960-8963.
17. Huang W, Kessler DS, Erikson RL (1995): Biochemical and biological analysis of Mek1 phosphorylation site mutants. Mol Biol Cell 6:237-245.
18. Kortenjann M, Shaw PE (1995): Raf-1 kinase and ERK2 uncoupled from mitogenic signals in rat fibroblasts. Oncogene 11:2105-2112.
19. Kortenjann M, Thomae O, Shaw PE (1994): Inhibition of v-Raf dependent c-fos expression and transformation by a kinase-defective mutant of the mitogen-activated protein kinase Erk2. Mol Cell Biol 14:4815-4824.
20. Kyriakis JM, App H, Zhang X-F, Banerjee P, Brautigan DL, Rapp UR, Avruch J (1992): Raf-1 activates MAP kinase-kinase. Nature 358:417-421.
21. Lange-Carter CA, Pleiman CM, Gardner AM, Blumer KJ, Johnson GL (1993): A divergence in the MAP kinase regulatory network defined by MEK kinase ans Raf. Science 260:315-319.
22. Mansour SJ, Matten WT, Hermann AS, Candia JM, Rong S, Fukasawa K, Vande Woude GF, Ahn NG (1994): Transformation of mammalian cells by constitutively active MAP kinase kinase. Science 265:966-970.
23. Nebreda AR, Hill C, Gomez N, Cohen P, Hunt T (1993): The protein kinase mos activates MAP kinase kinase in vitro and stimulates the MAP kinase pathway in mammalian somatic cells in vivo. FEBS Lett 333:183-187.
24. mapk are required for fibroblast proliferation. Proc Natl Acad Sci USA 90:8319-8323.
25. Pang L, Zheng C-F, Guan K-L, Saltiel AR (1995): Nerve growth factor stimulates a novel protein kinase in PC-12 cells that phosphorylates and activates mitogen activated protein kinase kinase (MEK). Biochem J 307:513-519.
26. Payne DM, Rossomando AJ, Martino P, Erickson AK, Her J-H, Shananowitz J, Hunt DF, Weber MJ, Sturgill TW (1991): Identification of the regulatory phosphorylation sites in pp42/mitogen-activated protein kinase (MAP kinase). EMBO J 10:885-892.
27. Reuter CWM, Catling AD, Jelinek T, Weber MJ (1995): Biochemical analysis of MEK activation in NIH3T3 fibroblasts. J Biol Chem 270:7644-7655.
28. Salmeron A, Ahmad TB, Carlile GW, Pappin D, Narsimhan RP, Ley SC (1996): Activation of MEK-1 and SEK-1 by Tpl-2 proto-oncoprotein, a novel MAP kinase kinase kinase. EMBO J 15:817-826.
29. Seger R, Seger D, Reszka AA, Munar ES, Eldar-Finkelman H, Dobrowolska G, Jensen AM, Campbell JS, Fisher EH, Krebs EG (1994): Overexpression of mitogen-activated protein kinase kinase (MAPKK) and its mutants in NIH 3T3 cells. J Biol Chem 269:25699-25709.
30. Sturgill TW, Ray LB, Erikson E, Maller JL (1988): Insulin-stimulated MAP-2 kinase phosphorylates and activates ribosomal protein S6 kinase II. Nature 334:715-718.
31. Vaillancourt RR, Gardner AM, Johnson GL (1994): B-Raf-dependent regulation of the MEK-1/mitogen-activated protein kinase pathway in PC12 cells and regulation by cyclic AMP. Mol Cell Biol 14:6522-6530.
32. Wang LM, Keegan AD, Paul WE, Heidaran MA, Gutkind JS, Pierce JH (1992): IL-4 activates a distinct signal transduction cascade from IL-3 in factor-dependent myeloid cells. EMBO J 11:4899-4908.
33. Waters SB, Holt KH, Ross SE, Syu LJ, Guan KL, Saltiel AR, Koretzky GA, Pessin JE (1995): Desensitization of Ras activation by a feedback disassociation of the SOS-Grb2 complex. J Biol Chem 270:20883-20886.
34. Wither DJ, Bloom SR, Rozengurt E (1995): Dissociation of cAMP-stimulated mitogenesis from activation of the mitogen-activated protein kinase cascade in Swiss 3T3 cells. J Biol Chem 270:21411-21419.
35. Wu X, Noh SJ, Zhou G, Dixon JE, Guan K-L (1996): Selective activation of MEK1 but not MEK2 by A-raf from EGF stimulated Hela cells. J Biol Chem 271:3265-3271.
36. Zheng C-F, Guan K-L (1994): Activation of MEK family kinases requires phosphorylation of two conserved Ser/ Thr residues. EMBO J 13:1123-1131.